Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Down syndrome--recent progress and future prospects.

Wiseman FK, Alford KA, Tybulewicz VL, Fisher EM.

Hum Mol Genet. 2009 Apr 15;18(R1):R75-83. doi: 10.1093/hmg/ddp010. Review.

2.

Down syndrome: genes, model systems, and progress towards pharmacotherapies and clinical trials for cognitive deficits.

Busciglio J, Capone G, O'Bryan J, Gardiner KJ.

Cytogenet Genome Res. 2013;141(4):260-71. doi: 10.1159/000354306. Epub 2013 Aug 30. Erratum in: Cytogenet Genome Res. 2014;142(2):94. O'Byran, J P [corrected to O'Bryan, J].

PMID:
24008277
3.

Molecular genetic analysis of Down syndrome.

Patterson D.

Hum Genet. 2009 Jul;126(1):195-214. doi: 10.1007/s00439-009-0696-8. Epub 2009 Jun 13. Review.

PMID:
19526251
4.

Using mouse models to explore genotype-phenotype relationship in Down syndrome.

Salehi A, Faizi M, Belichenko PV, Mobley WC.

Ment Retard Dev Disabil Res Rev. 2007;13(3):207-14. Review.

PMID:
17910089
5.

Trisomy 21 and Down syndrome: a short review.

Sommer C, Henrique-Silva F.

Braz J Biol. 2008 May;68(2):447-52. Review.

6.

A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions.

Yu T, Li Z, Jia Z, Clapcote SJ, Liu C, Li S, Asrar S, Pao A, Chen R, Fan N, Carattini-Rivera S, Bechard AR, Spring S, Henkelman RM, Stoica G, Matsui S, Nowak NJ, Roder JC, Chen C, Bradley A, Yu YE.

Hum Mol Genet. 2010 Jul 15;19(14):2780-91. doi: 10.1093/hmg/ddq179. Epub 2010 May 4.

7.

The power of comparative and developmental studies for mouse models of Down syndrome.

Moore CS, Roper RJ.

Mamm Genome. 2007 Jul;18(6-7):431-43. Epub 2007 Jul 26. Review.

8.

Mouse models for Down syndrome-associated developmental cognitive disabilities.

Liu C, Belichenko PV, Zhang L, Fu D, Kleschevnikov AM, Baldini A, Antonarakis SE, Mobley WC, Yu YE.

Dev Neurosci. 2011;33(5):404-13. doi: 10.1159/000329422. Epub 2011 Aug 25. Review.

9.

Down syndrome mouse models are looking up.

Reeves RH.

Trends Mol Med. 2006 Jun;12(6):237-40. Epub 2006 May 4.

PMID:
16677859
10.

Neurotransmitter-based strategies for the treatment of cognitive dysfunction in Down syndrome.

Das D, Phillips C, Hsieh W, Sumanth K, Dang V, Salehi A.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Oct 3;54:140-8. doi: 10.1016/j.pnpbp.2014.05.004. Epub 2014 May 17. Review.

PMID:
24842803
11.

The cognitive phenotype of Down syndrome: insights from intracellular network analysis.

Ma'ayan A, Gardiner K, Iyengar R.

NeuroRx. 2006 Jul;3(3):396-406. Review.

12.

Murine models for Down syndrome.

Dierssen M, Fillat C, Crnic L, Arbonés M, Flórez J, Estivill X.

Physiol Behav. 2001 Aug;73(5):859-71. Review.

PMID:
11566219
13.

Pathways to cognitive deficits in Down syndrome.

Sturgeon X, Le T, Ahmed MM, Gardiner KJ.

Prog Brain Res. 2012;197:73-100. doi: 10.1016/B978-0-444-54299-1.00005-4. Review.

PMID:
22541289
14.

Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse background in the Tc1 model of Down syndrome.

Gribble SM, Wiseman FK, Clayton S, Prigmore E, Langley E, Yang F, Maguire S, Fu B, Rajan D, Sheppard O, Scott C, Hauser H, Stephens PJ, Stebbings LA, Ng BL, Fitzgerald T, Quail MA, Banerjee R, Rothkamm K, Tybulewicz VL, Fisher EM, Carter NP.

PLoS One. 2013 Apr 15;8(4):e60482. doi: 10.1371/journal.pone.0060482. Print 2013.

15.

Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21.

Lyle R, Béna F, Gagos S, Gehrig C, Lopez G, Schinzel A, Lespinasse J, Bottani A, Dahoun S, Taine L, Doco-Fenzy M, Cornillet-Lefèbvre P, Pelet A, Lyonnet S, Toutain A, Colleaux L, Horst J, Kennerknecht I, Wakamatsu N, Descartes M, Franklin JC, Florentin-Arar L, Kitsiou S, Aït Yahya-Graison E, Costantine M, Sinet PM, Delabar JM, Antonarakis SE.

Eur J Hum Genet. 2009 Apr;17(4):454-66. doi: 10.1038/ejhg.2008.214. Epub 2008 Nov 12.

16.

From abnormal hippocampal synaptic plasticity in down syndrome mouse models to cognitive disability in down syndrome.

Cramer N, Galdzicki Z.

Neural Plast. 2012;2012:101542. doi: 10.1155/2012/101542. Epub 2012 Jul 12. Review.

17.

The telomeric part of the human chromosome 21 from Cstb to Prmt2 is not necessary for the locomotor and short-term memory deficits observed in the Tc1 mouse model of Down syndrome.

Duchon A, Pothion S, Brault V, Sharp AJ, Tybulewicz VL, Fisher EM, Herault Y.

Behav Brain Res. 2011 Mar 1;217(2):271-81. doi: 10.1016/j.bbr.2010.10.023. Epub 2010 Oct 31.

18.

Gene therapy for Down syndrome.

Fillat C, Altafaj X.

Prog Brain Res. 2012;197:237-47. doi: 10.1016/B978-0-444-54299-1.00012-1. Review.

PMID:
22541296
19.

Genetic mechanisms involved in the phenotype of Down syndrome.

Patterson D.

Ment Retard Dev Disabil Res Rev. 2007;13(3):199-206. Review.

PMID:
17910086
20.

Down syndrome: searching for the genetic culprits.

Lana-Elola E, Watson-Scales SD, Fisher EM, Tybulewicz VL.

Dis Model Mech. 2011 Sep;4(5):586-95. doi: 10.1242/dmm.008078. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk